Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adriana Andrade, MD, MPH
Johns Hopkins University
Study Chair - Edgar T Overton, MD
University of Alabama at Birmingham
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico-Aids Crs (5401)
San Juan, Puerto Rico
- 31788 Alabama Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs (601)
Los Angeles, California, United States
- 701 University of California, San Diego Antiviral Research Center Crs
San Diego, California, United States
- 801 University of California, San Francisco Hiv/aids Crs
San Francisco, California, United States
- University of Colorado Hospital Crs (6101)
Aurora, Colorado, United States
- Northwestern University Crs (2701)
Chicago, Illinois, United States
- Rush University Medical Center (2702)
Chicago, Illinois, United States
- Johns Hopkins Adult Aids Crs (201)
Baltimore, Maryland, United States
- Washington University Crs (2101)
St Louis, Missouri, United States
- 31786 New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- 7803 Weill Cornell Upton Crs
New York, New York, United States
- 7804 Weill Cornell Chelsea Crs
New York, New York, United States
- Columbia Physicians and Surgeons Crs (30329)
New York, New York, United States
- Unc Aids Crs (3201)
Chapel Hill, North Carolina, United States
- Greensboro Crs (3203)
Greensboro, North Carolina, United States
- University of Cincinnati Crs (2401)
Cincinnati, Ohio, United States
- Case Crs (2501)
Cleveland, Ohio, United States
- the Ohio State University Aids Crs (2301)
Columbus, Ohio, United States
- 6201 Penn Therapeutics Crs
Philadelphia, Pennsylvania, United States
- Pittsburgh Crs (1001)
Pittsburgh, Pennsylvania, United States
- Vanderbilt Therapeutics Crs (3652)
Nashville, Tennessee, United States
- Trinity Health and Wellness Center Crs (31443)
Dallas, Texas, United States
- Houston Aids Research Team Crs (31473)
Houston, Texas, United States
- University of Washington Aids Crs (1401)
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2016
- Primary completion
- 5 Jun 2017
- Completion
- 28 Aug 2017
- Last update posted
- 6 Jan 2020
- Registered enrollment
- 93
- Registry id
- NCT02706717
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.